REPUBLIC OF BULGARIA

NATIONAL COUNCIL ON PRICES AND REIMBURSEMENT OF MEDICINAL PRODUCTS

РЕПУБЛИКА БЪЛГАРИЯ

НАЦИОНАЛЕН СЪВЕТ ПО ЦЕНИ И РЕИМБУСИРАНЕ НА ЛЕКАРСТВЕНИ ПРОДУКТИ

Negative decision to include a medicinal product belonging to a new International Non-proprietary Name (INN) 2020

ADEMPAS, INN riociguat

ALOFISEL , INN darvadstrocel

Crysvita, INN Burosumab

DUPIXENT, INN dupilumab

GALAFOLD, INN Migalastat

XOFIGO, INN Radium (223Ra) dichloride